Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 34

Details

Autor(en) / Beteiligte
Titel
N‐Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury
Ist Teil von
  • Journal of neurochemistry, 2001-04, Vol.77 (2), p.408-415
Ort / Verlag
Oxford, UK: Blackwell Science Ltd
Erscheinungsjahr
2001
Link zum Volltext
Quelle
Wiley Online Library Journals Frontfile Complete
Beschreibungen/Notizen
  • To evaluate the contribution of cellular dysfunction and neuronal loss to brain N‐acetylaspartate (NAA) depletion, NAA was measured in brain tissue by HPLC and UV detection in rats subjected to cerebral injury, associated or not with cell death. When lesion was induced by intracarotid injection of microspheres, the fall in NAA was related to the degree of embolization and to the severity of brain oedema. When striatal lesion was induced by local injection of malonate, the larger the lesion volume, the higher the NAA depletion. However, reduction of brain oedema and striatal lesion by treatment with the lipophilic iron chelator dipyridyl (20 mg/kg, 1 h before and every 8 h after embolization) and the inducible nitric oxide synthase inhibitor aminoguanidine (100 mg/kg given 1 h before malonate and then every 9 h), respectively, failed to ameliorate the fall in NAA. Moreover, after systemic administration of 3‐nitropropionic acid, a marked reversible fall in NAA striatal content was observed despite the lack of tissue necrosis. Overall results show that cellular dysfunction can cause higher reductions in NAA level than neuronal loss, thus making of NAA quantification a potential tool for visualizing the penumbra area in stroke patients.
Sprache
Englisch
Identifikatoren
ISSN: 0022-3042
eISSN: 1471-4159
DOI: 10.1046/j.1471-4159.2001.00285.x
Titel-ID: cdi_hal_primary_oai_HAL_hal_00502168v1
Format
Schlagworte
2,2'-Dipyridyl, 2,2'-Dipyridyl - administration & dosage, 2,2'-Dipyridyl - pharmacology, 2,2'-Dipyridyl - therapeutic use, 3-Nitropropionic acid, Acute Disease, aminoguanidine, Animals, Aspartic Acid, Aspartic Acid - analogs & derivatives, Aspartic Acid - analysis, Biological and medical sciences, Biological Markers, Biomarkers, Brain Chemistry, Brain Edema, Brain Edema - etiology, Brain Edema - metabolism, Brain Edema - pathology, brain ischaemia, Brain Ischemia, Brain Ischemia - etiology, Brain Ischemia - metabolism, Brain Ischemia - pathology, Carotid Arteries, Cell Death, Chromatography, High Pressure Liquid, Corpus Striatum, Corpus Striatum - drug effects, Corpus Striatum - metabolism, Corpus Striatum - pathology, dipyridyl, Disease Models, Animal, Enzyme Inhibitors, Enzyme Inhibitors - pharmacology, Guanidines, Guanidines - administration & dosage, Guanidines - pharmacology, Guanidines - therapeutic use, Injections, Intra-Arterial, Iron Chelating Agents, Iron Chelating Agents - administration & dosage, Iron Chelating Agents - pharmacology, Iron Chelating Agents - therapeutic use, Life Sciences, Male, Malonates, Malonates - toxicity, Medical sciences, Microspheres, Mitochondria, Mitochondria - drug effects, mitochondrial poisoning, N-Acetylaspartic acid, Nerve Tissue Proteins, Nerve Tissue Proteins - antagonists & inhibitors, Neurology, Neuroprotective Agents, Neuroprotective Agents - administration & dosage, Neuroprotective Agents - pharmacology, Neuroprotective Agents - therapeutic use, Nitric Oxide, Nitric Oxide - metabolism, Nitric Oxide Synthase, Nitric Oxide Synthase - antagonists & inhibitors, Nitro Compounds, N‐acetylaspartate, Oxidative Stress, Pharmaceutical sciences, Premedication, Propionates - toxicity, Propionic Acids, Rats, Rats, Wistar, Spectrophotometry, Ultraviolet, Succinate Dehydrogenase, Succinate Dehydrogenase - antagonists & inhibitors, Vascular diseases and vascular malformations of the nervous system

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX